Both in Pharmaceuticals
Mentari Therapeutics vs Maravai LifeSciences Holdings
| Metric | MTRI | MRVI |
|---|---|---|
| Price | $18.35 | $7.68 |
| Market cap | $1.07B | $1.15B |
| Today | +17.56% | −0.26% |
| 1 month | — | +17.3% |
| 6 months | — | +79.0% |
| Year to date | — | +136.3% |
| 1 year | — | +136.3% |
| Revenue growth (YoY) | — | +10.1% |
| Gross margin | — | 35.3% |
| Net margin | — | −30.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.4× |
| Net cash | — | -$103.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 73.1% |
| Short % of float | 0.2% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).